-+ 0.00%
-+ 0.00%
-+ 0.00%

Tianjin TEDA Biomedical Engineering swings to FY26 H1 profit of RMB 10.21 million; revenue rises 30.75% to RMB 296.03 million

PUBT·08/31/2026 13:51:07
Listen to the news
Tianjin TEDA Biomedical Engineering swings to FY26 H1 profit of RMB 10.21 million; revenue rises 30.75% to RMB 296.03 million
  • Tianjin TEDA Biomedical Engineering posted 1H 2026 revenue of RMB 296.03 million, up 30.75% year over year.
  • Gross profit more than doubled to RMB 33.36 million; gross margin widened 5.17 percentage points to 11.27%.
  • Profit attributable to owners swung to RMB 10.21 million; basic earnings per share were RMB 0.048 cents.
  • AI health and elderly care revenue climbed to RMB 106.37 million, driven by rollout of the “Xihe No.1” medical large model.
  • No interim dividend was recommended; the group reiterated plans to accelerate its shift toward an AI medical technology business.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tianjin TEDA Biomedical Engineering Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260831-12309628), on August 31, 2026, and is solely responsible for the information contained therein.